ArticleHuman vaccines & immunotherapeutics2016
What timing of vaccination is potentially dangerous for children younger than 2 years?
Article in Human vaccines & immunotherapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 28 citations in OpenAlex.
- Assessment of effectiveness of health education bundle to overcome vaccine hesitancy in mothers: single blinded randomized study.BMC research notes · 2025Trial
- Health literacy, awareness and referral patterns of mothers in childhood vaccination: a cross-sectional study in Iran.BMC public health · 2025Article
- Timeliness and Equity: An Analysis of Measles Herd Immunity in a Regional Area of Australia.Vaccines · 2025Article
- Immunization coverage and timeliness of vaccination in young patients with inborn errors of metabolism: a French multicentric study.Orphanet journal of rare diseases · 2025Article
- High coverage and timeliness of vaccination of children under 6 years of age in Risaralda, Colombia.Human vaccines & immunotherapeutics · 2023Article
- Factors related to parents' adherence to childhood immunization.BMC public health · 2022Article
- Predictors of Adherence to Routine Immunization Schedule Among Caretakers of Children Aged 10 to 18 Months in Lira City, Uganda.Global pediatric health · 2022Article
- Adherence to the paediatric immunisation schedule in England.Vaccine: X · 2021Article
- Mandatory Infant Vaccinations in France During the COVID-19 Pandemic in 2020.Frontiers in pediatrics · 2021Article
- Perception of general pediatricians in Riyadh towards vaccination of patients with congenital heart diseases.Journal of family medicine and primary care · 2020Article
- Timeliness of vaccination in infants followed by primary-care pediatricians in France.Human vaccines & immunotherapeutics · 2018Article
- Editorial on "What is a potentially damaging vaccination delay in children younger than 2 years?"Human vaccines & immunotherapeutics · 2016Article
- Reply to Editorial on "What is a potentially damaging vaccination delay in children younger than 2 years?"Human vaccines & immunotherapeutics · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vaccine-preventable diseases still occur although measured coverage rates at 2 y of age are high. The occurrence of these diseases may be explained in part by untimely, that is, late vaccination. Our objective was to identify potentially dangerous vaccination delays for each dose of each vaccine in children younger than 2 y. A 3-round Delphi process was conducted by e-mail. We recruited 37 French experts in vaccines for children: 16 from the Infovac-France group and 21 from the French study group for pediatric infectious diseases. Items were generated by a literature review for the 10 vaccine doses recommended before 2 y of age. Item reduction in round 1 and 2 and any consensus in round 3 used a 70% consensus cutoff. The mean participation rate was 79%. Delays that should not be exceeded were identified for all vaccine doses. The 70% consensus was reached for 6 of the 10 vaccine doses: 15 d after the recommended date for the first 2 doses of the diphtheria-tetanus-acellular pertussis-inactivated polio vaccine/Haemophilus influenzae b vaccine and for the second dose of the pneumococcal conjugate vaccine, 1 month for the meningococcal C vaccine and for the first dose of the measles-mumps-rubella vaccine, and 11 y of age for completion of the hepatitis B vaccination. This Delphi process identified potentially dangerous vaccination delays for children to the age of 2 y. These can be used as new indicators in further studies of vaccine effectiveness and can help to improve the quality of vaccine protection in children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.